Qingdao NovelBeam Technology Co (688677) Fair Value & Analysis

Healthcare · CN · Market cap 13.2B CNY

Analysis

Qingdao NovelBeam Technology Co (688677) currently trades at ¥121.90, while our model-based Fair Value estimate is ¥31.30 — implying the stock looks roughly 74.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and optical devices and components, including dental endoscopes, light source modules for microscopes and PCR analysis, fluorescence filters, beauty machine filters, light sheets, and high-energy laser scanning mirror, etc. It also provides optical imaging solutions for clinical medicine; and identity information management solutions based on biometrics. Qingdao NovelBeam Technology Co.,Ltd. was founded in 2003 and is headquartered in Qingdao, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.